Questionnaire and Fall Risk Assessment

NCT00836238 | Completed

• 1 other identifier: 2008-0779
• Study Type: observational
• Target: 34
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this research study is to learn if your answers to questions during an interview can help researchers predict how well you function physically and if you are at a high risk for falls. Primary Objectives:

• To determine how accurately a simple questionnaire can predict three objective measures of function in elderly patients with prostate cancer. Secondary Objectives:
• To assess the correlations between three functional tests and the number of self-reported falls in elderly patients with prostate cancer.
• To determine risk factors related to number of falls in elderly prostate cancer patients.

Conditions

Prostate Cancer

Keywords

Prostate Cancer; Neural Functioning Assessment; Physical Assessment; Questionnaire; Objective Measures of Functional Status; Physical Function; Symptom Assessment Interview; Elderly

Outcome Measures

Primary Outcomes (1)

• Number Patient Falls + Activity Limitations Using Functional Tests

  45 minutes total to complete during already-scheduled clinic visit

Study Arms (1)

Questionnaire + Fall Risk Assessment

Physical Function Interview + Physical Function Tests + Symptom Assessment Interview

Behavioral: Interview; Other: Physical Function Tests

Interventions

Interview BEHAVIORAL

Physical Function and Symptom Assessment Interviews

Also known as: survey

Questionnaire + Fall Risk Assessment

Physical Function Tests OTHER

3 physical function tests.

Questionnaire + Fall Risk Assessment

Eligibility Criteria

• Age: 65 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Males with prostate cancer, 65 years of age or older, who able to ambulate with or without an assistive device, without assistance from a person.

You may qualify if:

• Patients must have the ability to understand and willingness to sign a written informed consent document.
• Patients must be able to ambulate with or without an assistive device, without assistance from a person.
• Patients must be 65 years old or older.
• Patients must have a diagnosis of prostate cancer
• Patients must have received androgen deprivation therapy (ADT) for their prostate cancer for at least 3 months and were responding to treatment as determined by prostate-specific antigen criteria.
• Patients have received chemotherapy within last month.
• Patients must speak English.

You may not qualify if:

• Patients who decline to participate or who are determined incapable of completing the study.
• Active Central Nervous System (CNS) disease such as clinically-evident CNS metastases or leptomeningeal disease, dementia, or encephalopathy (per treating physician's assessment).

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

UT MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• UT MD Anderson Cancer Center website

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Interviews as Topic; Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Ying Guo, MD

  UT MD Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 26, 2009
• First Posted: February 4, 2009
• Study Start: February 1, 2009
• Primary Completion: June 1, 2009
• Study Completion: June 1, 2009
• Last Updated: August 1, 2012

Record last verified: 2012-07

Locations

US (1)